110 related articles for article (PubMed ID: 8981331)
21. Proteoglycans of basement membranes.
Timpl R
Experientia; 1993 May; 49(5):417-28. PubMed ID: 8500597
[TBL] [Abstract][Full Text] [Related]
22. Localization of binding sites for laminin, heparan sulfate proteoglycan and fibronectin on basement membrane (type IV) collagen.
Laurie GW; Bing JT; Kleinman HK; Hassell JR; Aumailley M; Martin GR; Feldmann RJ
J Mol Biol; 1986 May; 189(1):205-16. PubMed ID: 2946868
[TBL] [Abstract][Full Text] [Related]
23. Widespread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against domain III and by in situ hybridization.
Murdoch AD; Liu B; Schwarting R; Tuan RS; Iozzo RV
J Histochem Cytochem; 1994 Feb; 42(2):239-49. PubMed ID: 7507142
[TBL] [Abstract][Full Text] [Related]
24. Structural basis of beta 1 integrin-mediated cell adhesion to a large heparan sulfate proteoglycan from basement membranes.
Battaglia C; Aumailley M; Mann K; Mayer U; Timpl R
Eur J Cell Biol; 1993 Jun; 61(1):92-9. PubMed ID: 7693469
[TBL] [Abstract][Full Text] [Related]
25. Proteoglycans of basement membranes.
Timpl R
EXS; 1994; 70():123-44. PubMed ID: 8298244
[TBL] [Abstract][Full Text] [Related]
26. Activin A binds to perlecan through its pro-region that has heparin/heparan sulfate binding activity.
Li S; Shimono C; Norioka N; Nakano I; Okubo T; Yagi Y; Hayashi M; Sato Y; Fujisaki H; Hattori S; Sugiura N; Kimata K; Sekiguchi K
J Biol Chem; 2010 Nov; 285(47):36645-55. PubMed ID: 20843788
[TBL] [Abstract][Full Text] [Related]
27. Mapping of the binding of platelet-derived growth factor to distinct domains of the basement membrane proteins BM-40 and perlecan and distinction from the BM-40 collagen-binding epitope.
Göhring W; Sasaki T; Heldin CH; Timpl R
Eur J Biochem; 1998 Jul; 255(1):60-6. PubMed ID: 9692901
[TBL] [Abstract][Full Text] [Related]
28. Perlecan, the large low-density proteoglycan of basement membranes: structure and variant forms.
Noonan DM; Hassell JR
Kidney Int; 1993 Jan; 43(1):53-60. PubMed ID: 8433569
[TBL] [Abstract][Full Text] [Related]
29. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease.
Snow AD; Kinsella MG; Parks E; Sekiguchi RT; Miller JD; Kimata K; Wight TN
Arch Biochem Biophys; 1995 Jun; 320(1):84-95. PubMed ID: 7793988
[TBL] [Abstract][Full Text] [Related]
30. Human perlecan immunopurified from different endothelial cell sources has different adhesive properties for vascular cells.
Whitelock JM; Graham LD; Melrose J; Murdoch AD; Iozzo RV; Underwood PA
Matrix Biol; 1999 Apr; 18(2):163-78. PubMed ID: 10372557
[TBL] [Abstract][Full Text] [Related]
31. Complementary expression of HIP, a cell-surface heparan sulfate binding protein, and perlecan at the human fetal-maternal interface.
Rohde LH; Janatpore MJ; McMaster MT; Fisher S; Zhou Y; Lim KH; French M; Hoke D; Julian J; Carson DD
Biol Reprod; 1998 Apr; 58(4):1075-83. PubMed ID: 9546743
[TBL] [Abstract][Full Text] [Related]
32. The proteoglycan perlecan is expressed in the erythroleukemia cell line K562 and is upregulated by sodium butyrate and phorbol ester.
Grässel S; Cohen IR; Murdoch AD; Eichstetter I; Iozzo RV
Mol Cell Biochem; 1995 Apr; 145(1):61-8. PubMed ID: 7544867
[TBL] [Abstract][Full Text] [Related]
33. Expression of the basement membrane heparan sulfate proteoglycan (perlecan) in human synovium and in cultured human synovial cells.
Dodge GR; Boesler EW; Jimenez SA
Lab Invest; 1995 Nov; 73(5):649-57. PubMed ID: 7474938
[TBL] [Abstract][Full Text] [Related]
34. Drosophila laminin binds to mammalian nidogen and to heparan sulfate proteoglycan.
Mayer U; Mann K; Fessler LI; Fessler JH; Timpl R
Eur J Biochem; 1997 May; 245(3):745-50. PubMed ID: 9183014
[TBL] [Abstract][Full Text] [Related]
35. Interaction of skeletal muscle cells with collagen type IV is mediated by perlecan associated with the cell surface.
Villar MJ; Hassell JR; Brandan E
J Cell Biochem; 1999 Dec; 75(4):665-74. PubMed ID: 10572249
[TBL] [Abstract][Full Text] [Related]
36. Expression of human perlecan domain I as a recombinant heparan sulfate proteoglycan with 20-kDa glycosaminoglycan chains.
Graham LD; Whitelock JM; Underwood PA
Biochem Biophys Res Commun; 1999 Mar; 256(3):542-8. PubMed ID: 10080934
[TBL] [Abstract][Full Text] [Related]
37. Antibody mapping and tissue localization of globular and cysteine-rich regions of perlecan domain III.
Couchman JR; Ljubimov AV; Sthanam M; Horchar T; Hassell JR
J Histochem Cytochem; 1995 Sep; 43(9):955-63. PubMed ID: 7543915
[TBL] [Abstract][Full Text] [Related]
38. Perlecan: a gem of a proteoglycan.
Iozzo RV
Matrix Biol; 1994 Apr; 14(3):203-8. PubMed ID: 7921536
[TBL] [Abstract][Full Text] [Related]
39. Mapping of binding sites for nidogens, fibulin-2, fibronectin and heparin to different IG modules of perlecan.
Hopf M; Göhring W; Mann K; Timpl R
J Mol Biol; 2001 Aug; 311(3):529-41. PubMed ID: 11493006
[TBL] [Abstract][Full Text] [Related]
40. An interaction between basement membrane and Alzheimer amyloid precursor proteins suggests a role in the pathogenesis of Alzheimer's disease.
Narindrasorasak S; Altman RA; Gonzalez-DeWhitt P; Greenberg BD; Kisilevsky R
Lab Invest; 1995 Mar; 72(3):272-82. PubMed ID: 7898047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
